EA201001087A1 - Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их - Google Patents

Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их

Info

Publication number
EA201001087A1
EA201001087A1 EA201001087A EA201001087A EA201001087A1 EA 201001087 A1 EA201001087 A1 EA 201001087A1 EA 201001087 A EA201001087 A EA 201001087A EA 201001087 A EA201001087 A EA 201001087A EA 201001087 A1 EA201001087 A1 EA 201001087A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
dihydroindolonic
new
production
pharmaceutical compositions
Prior art date
Application number
EA201001087A
Other languages
English (en)
Other versions
EA019481B1 (ru
Inventor
Жан-Клод Ортюно
Алексис Корди
Жан-Мишель Лакост
Имре Фейеш
Майкл Бёрбридж
Джон Хикман
Ален Пьерр
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA201001087A1 publication Critical patent/EA201001087A1/ru
Publication of EA019481B1 publication Critical patent/EA019481B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Storage Device Security (AREA)
  • Computer And Data Communications (AREA)

Abstract

Соединения формулы (I)в которой m и n означают 1 или 2, А означает пирролильную группу, Х означает С(O), S(O) или SOгруппу, Rи Rозначают алкильную группу или вместе с атомом азота, несущим их, образуют гетероциклическую группу, Rи Rвместе с атомами, несущими их, образуют гетероциклическую группу, Rозначает атом водорода или алкильную группу, Rозначает атом водорода или атом галогена. Лекарственные средства.
EA201001087A 2009-08-04 2010-08-03 Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их EA019481B1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903839A FR2948940B1 (fr) 2009-08-04 2009-08-04 Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
EA201001087A1 true EA201001087A1 (ru) 2011-04-29
EA019481B1 EA019481B1 (ru) 2014-04-30

Family

ID=41796204

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001087A EA019481B1 (ru) 2009-08-04 2010-08-03 Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их

Country Status (43)

Country Link
US (3) US8133889B2 (ru)
EP (1) EP2281822B1 (ru)
JP (2) JP5475588B2 (ru)
KR (1) KR101309101B1 (ru)
CN (1) CN101987848B (ru)
AP (1) AP2756A (ru)
AR (1) AR077510A1 (ru)
AU (1) AU2010203305B2 (ru)
BR (1) BRPI1003241A2 (ru)
CA (1) CA2710224C (ru)
CL (1) CL2010000804A1 (ru)
CO (1) CO6320143A1 (ru)
CU (1) CU23921B1 (ru)
CY (1) CY1113914T1 (ru)
DK (1) DK2281822T3 (ru)
EA (1) EA019481B1 (ru)
EC (1) ECSP10010380A (ru)
ES (1) ES2403227T3 (ru)
FR (1) FR2948940B1 (ru)
GE (1) GEP20125548B (ru)
HK (1) HK1155742A1 (ru)
HN (1) HN2010001537A (ru)
HR (1) HRP20130327T1 (ru)
IL (1) IL207183A (ru)
JO (1) JO2808B1 (ru)
MA (1) MA32184B1 (ru)
ME (1) ME01491B (ru)
MX (1) MX2010008557A (ru)
MY (1) MY183326A (ru)
NI (1) NI201000134A (ru)
NZ (1) NZ586993A (ru)
PE (1) PE20110206A1 (ru)
PL (1) PL2281822T3 (ru)
PT (1) PT2281822E (ru)
RS (1) RS52701B (ru)
SA (1) SA110310634B1 (ru)
SG (1) SG168499A1 (ru)
SI (1) SI2281822T1 (ru)
TW (1) TWI408138B (ru)
UA (1) UA105357C2 (ru)
UY (1) UY32801A (ru)
WO (1) WO2011015728A1 (ru)
ZA (1) ZA201005424B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA032217B1 (ru) * 2015-07-31 2019-04-30 Ле Лаборатуар Сервье Новое сочетание 3-[(3-{[4-(4-морфолинилметил)-1h-пиррол-2-ил]метилен}-2-оксо-2,3-дигидро-1h-индол-5-ил)метил]-1,3-тиазолидин-2,4-диона и ингибитора тирозинкиназы egfr

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR3008411B1 (fr) * 2013-07-12 2015-07-03 Servier Lab Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent
US10245270B2 (en) * 2013-07-12 2019-04-02 Les Laboratoires Servier Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it
JP6156845B2 (ja) * 2014-03-04 2017-07-05 株式会社島津製作所 マトリックス支援レーザ脱離イオン化質量分析用マトリックス
US10343991B2 (en) * 2016-11-02 2019-07-09 Council Of Scientific & Industrial Research C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof
US11897867B2 (en) 2017-08-04 2024-02-13 Bayer Aktiengesellschaft 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer
JOP20200024A1 (ar) * 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
CN113845524B (zh) * 2021-10-29 2023-11-07 四川农业大学 一种螺吡咯吲哚酮类化合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0892248A (ja) * 1994-09-26 1996-04-09 Yamanouchi Pharmaceut Co Ltd インドリノン誘導体
AU5468499A (en) * 1998-08-04 2000-02-28 Sugen, Inc. 3-methylidenyl-2-indolinone modulators of protein kinase
CN1138773C (zh) * 1998-12-17 2004-02-18 霍夫曼-拉罗奇有限公司 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂
CA2377513A1 (en) 1999-06-25 2001-01-04 Universitat Zurich Hetero-associating coiled-coil peptides
ATE369359T1 (de) * 2000-02-15 2007-08-15 Sugen Inc Pyrrol substituierte indolin-2-on protein kinase inhibitoren
AR042586A1 (es) * 2001-02-15 2005-06-29 Sugen Inc 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
CA2470480C (en) * 2001-12-27 2010-12-14 Theravance, Inc. Indolinone derivatives useful as protein kinase inhibitors
US7012088B2 (en) * 2003-02-24 2006-03-14 Pharmacia & Upjohn Company Indolone oxazolidinones and derivatives thereof
AU2004284084A1 (en) * 2003-10-24 2005-05-06 Schering Aktiengesellschaft Indolinone derivatives and their use in treating disease-states such as cancer
US7378530B2 (en) 2005-02-22 2008-05-27 Nereus Pharmaceuticals, Inc. Anti-cancer and anti-microbial 5-membered heterocyclic compounds
KR20080083341A (ko) * 2005-12-29 2008-09-17 더 스크립스 리서치 인스티튜트 인돌리논의 아미노산 유도체 기재의 단백질 키나제 억제제
FR2948940B1 (fr) 2009-08-04 2011-07-22 Servier Lab Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA032217B1 (ru) * 2015-07-31 2019-04-30 Ле Лаборатуар Сервье Новое сочетание 3-[(3-{[4-(4-морфолинилметил)-1h-пиррол-2-ил]метилен}-2-оксо-2,3-дигидро-1h-индол-5-ил)метил]-1,3-тиазолидин-2,4-диона и ингибитора тирозинкиназы egfr

Also Published As

Publication number Publication date
MY183326A (en) 2021-02-18
AU2010203305B2 (en) 2015-02-05
US20130331380A1 (en) 2013-12-12
JP2013116908A (ja) 2013-06-13
US8653073B2 (en) 2014-02-18
CN101987848B (zh) 2014-06-18
KR20110014116A (ko) 2011-02-10
CU23921B1 (es) 2013-07-31
US20110034460A1 (en) 2011-02-10
SI2281822T1 (sl) 2013-04-30
MA32184B1 (fr) 2011-04-01
PL2281822T3 (pl) 2013-06-28
CO6320143A1 (es) 2011-09-20
AP2756A (en) 2013-09-30
RS52701B (en) 2013-08-30
CU20100157A7 (es) 2012-03-15
HK1155742A1 (en) 2012-05-25
UA105357C2 (ru) 2014-05-12
NZ586993A (en) 2012-01-12
AU2010203305A1 (en) 2011-02-24
EP2281822A1 (fr) 2011-02-09
TW201118092A (en) 2011-06-01
MX2010008557A (es) 2011-02-03
CA2710224C (fr) 2013-01-08
WO2011015728A1 (fr) 2011-02-10
ME01491B (me) 2014-04-20
CA2710224A1 (fr) 2011-02-04
JP5475588B2 (ja) 2014-04-16
HN2010001537A (es) 2013-05-06
ECSP10010380A (es) 2011-03-31
GEP20125548B (en) 2012-05-25
IL207183A (en) 2014-01-30
FR2948940B1 (fr) 2011-07-22
KR101309101B1 (ko) 2013-09-16
CL2010000804A1 (es) 2011-08-26
EA019481B1 (ru) 2014-04-30
EP2281822B1 (fr) 2013-01-16
HRP20130327T1 (hr) 2013-05-31
BRPI1003241A2 (pt) 2012-04-10
UY32801A (es) 2011-01-31
AP2010005343A0 (en) 2010-08-31
JP2011037848A (ja) 2011-02-24
JP5538580B2 (ja) 2014-07-02
DK2281822T3 (da) 2013-04-22
SA110310634B1 (ar) 2013-11-10
ES2403227T3 (es) 2013-05-16
PT2281822E (pt) 2013-02-27
IL207183A0 (en) 2010-12-30
CY1113914T1 (el) 2016-07-27
SG168499A1 (en) 2011-02-28
CN101987848A (zh) 2011-03-23
AR077510A1 (es) 2011-08-31
PE20110206A1 (es) 2011-04-09
US20120046287A1 (en) 2012-02-23
NI201000134A (es) 2014-02-11
ZA201005424B (en) 2011-04-28
FR2948940A1 (fr) 2011-02-11
US8133889B2 (en) 2012-03-13
JO2808B1 (en) 2014-09-15
TWI408138B (zh) 2013-09-11
US8541412B2 (en) 2013-09-24

Similar Documents

Publication Publication Date Title
EA201001087A1 (ru) Новые дигидроиндолоновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
MY177250A (en) Novel nicotinamide derivative or salt thereof
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
EA201170772A1 (ru) Органические соединения
EA200900397A1 (ru) Новые соединения диосметина, способ их получения и фармацевтические композиции, которые их содержат
EA201000883A1 (ru) Производные индолинона и способ их получения
MX2012006805A (es) Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa.
EA201390374A1 (ru) Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина
EA200801681A1 (ru) Новые многократно замещенные соединения пиридиниламиноалкилен- и пиридинилоксиалкиленциклопропанамина, способ их получения и фармацевтические композиции, которые их содержат
CY1110944T1 (el) Νεα παραγωγα κυκλοαλκυλιωμενων βενζοθειαδιαζινων, μεθοδος παρασκευης αυτων και οι φαρμακευτικες συνθεσεις που τα περιεχουν
MA32342B1 (fr) Nouveaux derives chromeniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
UY33927A (es) Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
CU20130037A7 (es) Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen
EA200601248A1 (ru) Новые многократно замещённые соединения 1,1-пиридилоксициклопропанамина, способ их получения и фармацевтические композиции, которые их содержат
EA201000867A1 (ru) Новые соединения 2-меркаптоциклопентанкарбоновой кислоты, способ их получения и содержащие их фармацевтические композиции
EA201201674A1 (ru) Способы разделения замещенных по атому азота производных (s)-5-алкокси-2-аминотетралина
EA200900692A1 (ru) Новые азабициклические соединения, способ их получения и фармацевтические композиции, которые их содержат
MA33882B1 (fr) Nouveaux derives azabicyclo [3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EA200801566A1 (ru) Новые гетероциклические соединения оксима, способ их получения и фармацевтические композиции, которые их содержат
EA201100142A1 (ru) Циклические сулфоны, замещенные аминобензилом, применимые в качестве ингибиторов васе
TN2010000350A1 (en) New dihydroindolone compounds a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU